PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity

Abstract

PHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic. On treatment, different cell lines respond differentially, suggesting the absence of critical cell cycle checkpoints that could be the basis for a favorable therapeutic window.